Document text
Principal Investigator: Christine Marie Durand
Organization: JOHNS HOPKINS UNIVERSITY
Fiscal Year: 2021
Award: $6,941,821
Funding agency: National Institute of Allergy and Infectious Diseases
Solid organ transplant recipients experience high mortality from COVID-19 due to a combination of
immunosuppression and comorbidities. Although SARS-CoV-2 vaccination has been highly effective in the
general population, recent studies show that solid organ transplant recipients are less likely to develop
protective antibody responses. In addition, long term studies of safety, including immunologic sequela such as
rejection, and de novo donor-specific antibody formation are lacking.
We propose a Multicenter Randomized Adaptive Design Trial to investigate strategies for CPAT (COVID
Protection After Transplant). This trial will build on results from a CPAT Pilot Trial in 200 kidney transplant
reipients which will investigate the safety and immunogenicity of 3rd dose of a SARS-CoV-2 mRNA vaccines in
recipients who fail to develop high level antibodies after a standard 2 dose series. That trial will identify key
correlates of risk and efficacy. This trial will incorporate that data to investigate additional protective strategies
including the use of different vaccine platforms and changes in immunosuppression in 800 solid organ
transplant recipients with suboptimal anti-spike antibody responses across 15 US transplant centers. This trial
will personalize randomization to candidate arms with the highest probability of success using a Bayesian
framework. In conjuction, we will perform novel, comprehensive virologic and immunologic mechanistic studies
to better understand vaccine-associated immunity over time.
Our multidisciplinary team includes experts in Transplant Surgery, Infectious Diseases, Epidemiology,
Biostatistics, Pathology, Virology, and Immunology. Our team has experience successfully enrolling and
conducting multicenter transplantation trials (U01AI134591, U01AI138897) and will leverage existing
infrastructure for operations, data management, analysis, and safety reporting.
In summary, this Multicenter Adaptive Design CPAT Trial will determine the immunogenicity and safety of
novel SARS-CoV-2 vaccination strategies in 800 transplant recipients across the United States. Important
mechanistic studies will further fundamental understanding of development of protective immune responses in
this vulnerable population.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><Ab response><Active Follow-up><Acute><Ad vector><Adenoviral Vector><Adenovirus Vector><Adjuvant><Antibodies><Antibody Formation><Antibody Production><Antibody Response><Antigenic Determinants><Antigens><Antimetabolites><Assay><Avidity><B-Cell Subsets><B-Lymphocyte Subsets><Bayesian Modeling><Bayesian adaptive designs><Bayesian adaptive models><Bayesian belief network><Bayesian belief updating model><Bayesian framework><Bayesian hierarchical model><Bayesian network model><Bayesian nonparametric models><Bayesian spatial data model><Bayesian spatial image models><Bayesian spatial models><Bayesian statistical models><Bayesian tracking algorithms><Binding Determinants><Bioassay><Biologic Assays><Biological Assay><Biometrics><Biometry><Biostatistics><Booster Immunization><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><COVID><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 associated death><COVID-19 associated fatality><COVID-19 associated mortality><COVID-19 crisis><COVID-19 death><COVID-19 epidemic><COVID-19 fatality><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 induced death><COVID-19 induced fatality><COVID-19 induced mortality><COVID-19 mortality><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 related death><COVID-19 related fatality><COVID-19 related mortality><COVID-19 vaccination><COVID-19 vaccine><COVID-19 virus><COVID19><COVID19 associated death><COVID19 associated fatality><COVID19 associated mortality><COVID19 crisis><COVID19 death><COVID19 epidemic><COVID19 fatality><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 induced death><COVID19 induced fatality><COVID19 induced mortality><COVID19 mortality><COVID19 pandemic><COVID19 public health crisis><COVID19 related death><COVID19 related fatality><COVID19 related mortality><COVID19 vaccination><COVID19 vaccine><COVID19 virus><CV-19><CV19><Cell Mediated Immunology><Cell-Mediated Immunity><Cellular Immunity><Class Switching><Class Switchings><CoV disease><CoV-2><CoV2><Coupled><Data><Development><Diabetes Mellitus><Dose><Dysfunction><ELISPOT><Effectiveness><Enrollment><Epitopes><Event><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Functional disorder><Futility><General Population><General Public><Goals><Grafting Procedure><Heart><Humoral Immunities><Immune memory><Immune response><Immunity><Immunochemical Immunologic><Immunocompetent><Immunodominant Antigenic Determinants><Immunodominant Determinants><Immunodominant Domains><Immunodominant Epitopes><Immunodominant Regions><Immunodominant Sites><Immunoglobulin Class Switching><Immunoglobulin Class Switchings><Immunologic><Immunologic Memory><Immunologic Subtyping><Immunological><Immunological Memory><Immunological response><Immunologically><Immunologics><Immunology><Immunomodulation><Immunophenotyping><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Infection><Infectious Disease Epidemiology><Infectious Epidemiology><Infrastructure><Intervention><Intervention Strategies><Isotype Switching><Isotype Switchings><Kidney><Kidney Grafting><Kidney Transplantation><Kidney Transplants><Kidney Urinary System><Libraries><Liver><Longitudinal Studies><Lung><Lung Respiratory System><Memory B Cell><Memory B-Lymphocyte><Messenger RNA><Metabolic><Monitor><Multi-Institutional Clinical Trial><Multi-center clinical trial><Multi-site clinical trial><Multicenter clinical trial><Multisite clinical trial><Organ><Organ Transplantation><Organ Transplants><Pathology><Patients><Peptides><Persons><Phenotype><Physiopathology><Pilot Projects><Population><Probability><Prospective cohort><RNA vaccine><RNA-based vaccine><Randomized><Reaction><Renal Grafting><Renal Transplantation><Renal Transplants><Reporting><Risk><Route><SARS corona virus 2><SARS-CoV-2><SARS-CoV-2 associated death><SARS-CoV-2 associated fatality><SARS-CoV-2 associated mortality><SARS-CoV-2 death><SARS-CoV-2 epidemic><SARS-CoV-2 fatality><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 induced death><SARS-CoV-2 induced fatality><SARS-CoV-2 induced mortality><SARS-CoV-2 mortality><SARS-CoV-2 pandemic><SARS-CoV-2 related death><SARS-CoV-2 related fatality><SARS-CoV-2 related mortality><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Safety><Secondary Immunization><Series><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Solid><Speed><Staining method><Stains><T cell receptor repertoire sequencing><T cell receptor sequencing><T cell response><T8 Cells><T8 Lymphocytes><TCR repertoire sequencing><TCR sequencing><TCR-seq><TCRseq><Technology><Time><Transplant Recipients><Transplantation><Transplantation Surgery><United States><Vaccinated><Vaccination><Vaccine Antigen><Vaccines><Virus><Virus-like particle><Vulnerable Populations><Wuhan coronavirus><active followup><adeno vector><adenovector><anamnestic reaction><antibody biosynthesis><antibody-based immunity><antigen-specific T cells><arm><booster vaccination><co-morbid><co-morbidity><comorbidity><corona virus disease><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus disease 2019 vaccine><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 associated death><coronavirus disease 2019 associated fatality><coronavirus disease 2019 associated mortality><coronavirus disease 2019 crisis><coronavirus disease 2019 death><coronavirus disease 2019 epidemic><coronavirus disease 2019 fatality><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 induced death><coronavirus disease 2019 induced fatality><coronavirus disease 2019 induced mortality><coronavirus disease 2019 mortality><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 related death><coronavirus disease 2019 related fatality><coronavirus disease 2019 related mortality><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><data management><death due to COVID-19><death due to COVID19><death due to SARS-CoV-2><death due to coronavirus disease 2019><death due to severe acute respiratory syndrome coronavirus 2><death in COVID><death in COVID-19><death in SARS-CoV-2><death in coronavirus disease><death in coronavirus disease 2019><death in severe acute respiratory syndrome coronavirus 2><design><designing><developmental><diabetes><donor antibodies><donor-specific antibody><elderly patient><enroll><enzyme linked immunospot assay><experience><fatality due to COVID-19><fatality due to COVID19><fatality due to SARS-CoV-2><fatality due to coronavirus disease 2019><fatality due to severe acute respiratory syndrome coronavirus 2><flow cytophotometry><follow up><follow-up><followed up><followup><hCoV19><hepatic body system><hepatic organ system><host response><immune competent><immune modulation><immune regulation><immune suppression><immune system response><immunogen><immunogenic><immunogenicity><immunoglobulin biosynthesis><immunologic reactivity control><immunomodulatory><immunophenotype><immunoregulation><immunoregulatory><immunoresponse><improved><interest><intervention arm><interventional strategy><kidney tx><long-term study><longitudinal outcome studies><longterm study><mRNA><mRNA vaccine><mRNA-based vaccine><mortality><mortality due to COVID-19><mortality due to COVID19><mortality due to SARS-CoV-2><mortality due to coronavirus disease 2019><mortality due to severe acute respiratory syndrome coronavirus 2><multidisciplinary><nCoV2><novel><older patient><operation><organ allograft><organ graft><organ xenograft><pathophysiology><pilot study><pilot trial><programs><pulmonary><randomisation><randomization><randomly assigned><renal><response><safety study><scRNA-seq><secondary immune response><severe acute respiratory syndrome coronavirus 2 associated death><severe acute respiratory syndrome coronavirus 2 associated fatality><severe acute respiratory syndrome coronavirus 2 associated mortality><severe acute respiratory syndrome coronavirus 2 death><severe acute respiratory syndrome coronavirus 2 fatality><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 induced death><severe acute respiratory syndrome coronavirus 2 induced fatality><severe acute respiratory syndrome coronavirus 2 induced mortality><severe acute respiratory syndrome coronavirus 2 mortality><severe acute respiratory syndrome coronavirus 2 related death><severe acute respiratory syndrome coronavirus 2 related fatality><severe acute respiratory syndrome coronavirus 2 related mortality><single cell RNA-seq><single cell RNAseq><single-cell RNA sequencing><success><transplant><transplant centers><transplant patient><treatment arm><trial design><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccination strategy><vaccination study><vaccination trial><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine for novel coronavirus><vaccine safety><vaccine study><vaccine trial><variants of concern><virology><virus-like nanoparticles><viruslike particle><vulnerable group>